Multiple RCTs (Löndahl 2010, Faglia 1996); Margolis 2013 registry study tempers effect size. Benefit established for Wagner Grade 3+.
Overview
Diabetic foot ulcer treatment is one of the strongest evidence-based HBOT indications. Multiple RCTs and meta-analyses show HBOT significantly reduces major amputation rates in Wagner Grade 3+ diabetic foot ulcers that have failed standard wound care. This is a UHMS-approved and insurance-covered indication.
How HBOT Works
DFU healing requires adequate tissue oxygenation, which diabetic microvascular disease compromises. HBOT elevates arterial oxygen tension and drives dissolved-plasma oxygen delivery to hypoxic wound beds. Repeated HBOT courses stimulate HIF-1α-driven angiogenesis, forming new capillary networks in previously hypoperfused tissue. HBOT also enhances neutrophil-mediated bacterial killing — particularly important given the frequent polymicrobial colonisation of chronic DFUs — and reduces oedema via mild vasoconstriction. TcPO₂ measurements document the improved tissue oxygenation and predict healing response.
Clinical Protocol
Typical protocol
30–40 sessions at 2.0–2.4 ATA, 90 minutes each
Evidence level
Strong (Level 1A) — UHMS approved
FDA / regulatory status
FDA-approved indication (Medicare coverage)
Standard DFU protocol: 2.4 ATA for 90 minutes per session, 5 days per week, with 5-minute air breaks every 20–30 minutes. Course of 30–40 sessions. Interim assessment at session 20; continuation requires documented progress. Pre-treatment TcPO₂ assessment is required for CMS reimbursement.
Cautions & Considerations
HBOT is adjunct to standard wound care — glycaemic control, offloading, debridement, infection management.
Hypoglycaemia risk during sessions in insulin-treated patients.
Course commitment of 30–40 sessions over 6–8 weeks.
Documented progress required for continued CMS coverage.
Key Research
Löndahl et al. 2010 (Diabetes Care)
Faglia et al. 1996
Cochrane 2015 systematic review
UHMS Indications Manual
Indexed studies
Hyperbaric Oxygen Therapy Facilitates Healing of Chronic Foot Ulcers in Patients with Diabetes (2010, Level 1, 2.5 ATA) — PMID 20427683
Lack of Effectiveness of Hyperbaric Oxygen Therapy for the Treatment of Diabetic Foot Ulcer (2013, Level 3, 2 ATA) — PMID 23835691
Tenth European Consensus Conference on Hyperbaric Medicine (ECHM) (2017, Level 5) — PMID 28357821